Answers are grounded in this paper and cite their sources.
Animal study demonstrates that adenoviral gene therapy reduces intimal hyperplasia in balloon-injured porcine arteries, indicating a method to limit vascular proliferative disorders.
Accumulation of vascular smooth muscle cells as a consequence of arterial injury is a major feature of vascular proliferative disorders. Molecular approaches to the inhibition of smooth muscle cell proliferation in these settings could potentially limit intimal expansion. This problem was approached by introducing adenoviral vectors encoding the herpesvirus thymidine kinase (tk) into porcine arteries that had been injured by a balloon on a catheter. These smooth muscle cells were shown to be infectable with adenoviral vectors, and introduction of the tk gene rendered them sensitive to the nucleoside analog ganciclovir. When this vector was introduced into porcine arteries immediately after a balloon injury, intimal hyperplasia decreased after a course of ganciclovir treatment. No major local or systemic toxicities were observed. These data suggest that transient expression of an enzyme that catalyzes the formation of a cytotoxic drug locally may limit smooth muscle cell proliferation in response to balloon injury.
No takes yet. Share an insight, caveat, or question.
Ohno et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: